Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs (Q43202669)
Jump to navigation
Jump to search
scientific article published in January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs |
scientific article published in January 2010 |
Statements
1 reference
Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs (English)
1 reference
Benjamin Druss
1 reference
Elaine H Morrato
1 reference
Daniel M Hartung
1 reference
Robert J Valuck
1 reference
Richard Allen
1 reference
Elizabeth Campagna
1 reference
John W Newcomer
1 reference
1 January 2010
1 reference
1 reference
Identifiers
1 reference